Is the the 2nd or 3rd week in a row we've had negative numbers? Catching and exceeding GL is all fine and good, but not if the sole reason is that the total O3 market is shrinking. Sorta seems like we hit a wall here, at least for the time being.
And crap, it's now 4:30 pm EDT on Friday and still no word about PR decision - crap - will make for a tense weekend when we should all be enjoying friends and family - will not surprise me if FDA throws one final FU at AMRN by not giving PR until next Tues, past the 60 day deadline, but if we get standard review this board will go absolutely apeshit, and with just cause. Personally I'll be POd because it means another year of paying $118/mo for V because Part D won't cover it until the next fiscal year - will actually be more like $129/mo because of AMRN's annual price increase.